-
EDITORIAL
Quo vadis, chemical industry in Europe?
D. Arns
-
COVER STORY
Indena’s Enhanced CDMO capabilities: A leap in high-potency manufacturing
-
CONTRACT MANUFACTURING
Precision as a growth lever for CDMO leaders: Key findings from Simon-Kucher’s 2025 CDMO growth report
K. F. Kekec, C. Simon, P. Anderson
-
ADVERTORIAL
Angelini Pharma – The Future of Generic Pharmaceuticals: Innovations and Trends
-
ANTIBODY-DRUG CONJUGATES
Reimagining Antibody-Drug Conjugates: The Rise of Novel Targets, Bispecific Antibodies and Dual Payloads
S. Evans
-
A WORD WITH
Paolo Tubertini – CEO of Olon
-
COLUMN: The M&A Catalyst
Mergers & Acquisitions in a Fragmenting World Not Just About Price: The M&A Panel That Redefined Strategic Fit
B. Comanita
-
A WORD WITH
Enrico Zodio, CEO of PROCOS
-
PROCESS ANALYTICS
Advancing Process Analytics in Pharma: Practical Strategies for PAT and QbD Adoption in Resource-Constrained Environments
W. Foley, E. Hillier
-
PATENT STRATEGIES
Patent strategies for biotech startup companies
M. Barbieri
-
PHARMACOVIGILANCE
Applying AI to adverse event case processing: sharpening the impact of pharmacovigilance
J. Cohan
-
ARTIFICIAL INTELLIGENCE
Artificial Intelligence (AI) Driven Machine Learning Modeling for Process Characterization of Dynamic Freeze Drying (Lyophilization) After Spray Freezing
H. Stamato, B. Luy, M. Plitzko
-
PROTACs
Bridging the Gap: How Pre-Formulation and Strategies Enable Scalable PROTAC Development
C. Grant
-
Quality and Supply Chain security
Safeguarding every R&D sample: how sustainable storage and smart scalability keep research viable
L. A. Ball
-
Panel Discussion on Biotech-CDMO Collaboration
